<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Paul Simenauer - Seeking Alpha</title>
    <description>'Paul Simenauer' Tag RSS Syndication from SeekingAlpha.com</description>
    <author>
      <name>SeekingAlpha.com</name>
    </author>
    <link>http://seekingalpha.com/author/paul-simenauer</link>
    <item>
      <title>Ark Restaurants Corp.: Growth Opportunities Abound</title>
      <link>http://seekingalpha.com/article/63756-ark-restaurants-corp-growth-opportunities-abound?source=feed</link>
      <guid isPermaLink="false">63756</guid>
      <content>
        <![CDATA[<p>
<span style="font-weight:bold;">Key Statistics</span>*<br />Mkt. Cap: $122.3M<br />P/E: 11.14x (FYE 9/29/2009)<br />EV/EBITDA: 7.47x <br />Yield: 5.5%<br />Operating Margin: 9.13%<br />ROE (ttm): 21.59%<br />Analyst Coverage: Dean Haskell of Morgan Joseph & Co. Inc.- PT of $45.00; 2009 EPS estimate of $2.93; 2009 Revenue estimate of $162.74M.<br />*<i> Source: Yahoo! Finance</i><!--more--><br /><br /><img src="http://static.seekingalpha.com/uploads/2008/2/8/arkr.gif" style="float: right; margin-left: 2px;" /><span style="font-weight:bold;">Profile</span>*<br /><span style="font-style:italic;">Ark Restaurants Corp., through its subsidiaries, engages in the ownership and operation of restaurants and bars, fast food concepts, catering operations, and wholesale and retail bakeries. As of September 29, 2007, it operated 23 restaurants and bars, including 7 facilities located in New York City; 4 in Washington, D.C.; 5 in Las Vegas; Nevada; 2 in Atlantic City, New Jersey; 3 at the Foxwoods Resort Casino in Ledyard, Connecticut; and 1 in the Faneuil Hall Marketplace in Boston, Massachusetts, as well as 24 fast food concepts, catering operations, and wholesale and retail bakeries. The company was founded in 1983 and is based in New York, New York.</span><br />*<i> Source: Yahoo! Finance</i></p>]]>
      </content>
      <pubDate>Fri, 08 Feb 2008 06:11:14 -0500</pubDate>
      <author>Paul Simenauer</author>
      <description>
        <![CDATA[<strong><a href="http://stockslinger.blogspot.com/">Paul Simenauer</a> submits: </strong><p>
<span style="font-weight:bold;">Key Statistics</span>*<br />Mkt. Cap: $122.3M<br />P/E: 11.14x (FYE 9/29/2009)<br />EV/EBITDA: 7.47x <br />Yield: 5.5%<br />Operating Margin: 9.13%<br />ROE (ttm): 21.59%<br />Analyst Coverage: Dean Haskell of Morgan Joseph & Co. Inc.- PT of $45.00; 2009 EPS estimate of $2.93; 2009 Revenue estimate of $162.74M.<br />*<i> Source: Yahoo! Finance</i><!--more--><br /><br /><img src="http://static.seekingalpha.com/uploads/2008/2/8/arkr.gif" style="float: right; margin-left: 2px;" /><span style="font-weight:bold;">Profile</span>*<br /><span style="font-style:italic;">Ark Restaurants Corp., through its subsidiaries, engages in the ownership and operation of restaurants and bars, fast food concepts, catering operations, and wholesale and retail bakeries. As of September 29, 2007, it operated 23 restaurants and bars, including 7 facilities located in New York City; 4 in Washington, D.C.; 5 in Las Vegas; Nevada; 2 in Atlantic City, New Jersey; 3 at the Foxwoods Resort Casino in Ledyard, Connecticut; and 1 in the Faneuil Hall Marketplace in Boston, Massachusetts, as well as 24 fast food concepts, catering operations, and wholesale and retail bakeries. The company was founded in 1983 and is based in New York, New York.</span><br />*<i> Source: Yahoo! Finance</i></p><br/><a href='http://seekingalpha.com/article/63756-ark-restaurants-corp-growth-opportunities-abound?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/arkr">ARKR</category>
      <category type="author" link="http://seekingalpha.com/author/paul-simenauer">Paul Simenauer</category>
    </item>
    <item>
      <title>The Short Case on INVESTools   </title>
      <link>http://seekingalpha.com/article/54509-the-short-case-on-investools?source=feed</link>
      <guid isPermaLink="false">54509</guid>
      <content>
        <![CDATA[ <p>
 
</p>
<p>INVESTools (SWIM), according to their most recent 10-k calls themselves "a leader in investor education," helping users achieve their goals by using the "INVESTools method." <!--more-->The company consists of four subsidiaries including ZiaSun, Telescan, and SES Acquisition Corp., and Prophet Financial Systems.<!--more--> INVESTools recently acquired retail broker Think or Swim, <a href='http://webreprints.djreprints.com/1662510805516.pdf'>rated highly by Barron's</a> (.pdf), for what that is worth.
</p>]]>
      </content>
      <pubDate>Fri, 16 Nov 2007 05:42:15 -0500</pubDate>
      <author>Paul Simenauer</author>
      <description>
        <![CDATA[<strong><a href="http://stockslinger.blogspot.com/">Paul Simenauer</a> submits: </strong> <p>
 
</p>
<p>INVESTools (SWIM), according to their most recent 10-k calls themselves "a leader in investor education," helping users achieve their goals by using the "INVESTools method." <!--more-->The company consists of four subsidiaries including ZiaSun, Telescan, and SES Acquisition Corp., and Prophet Financial Systems.<!--more--> INVESTools recently acquired retail broker Think or Swim, <a href='http://webreprints.djreprints.com/1662510805516.pdf'>rated highly by Barron's</a> (.pdf), for what that is worth.
</p><br/><a href='http://seekingalpha.com/article/54509-the-short-case-on-investools?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/swim">SWIM</category>
      <category type="author" link="http://seekingalpha.com/author/paul-simenauer">Paul Simenauer</category>
    </item>
    <item>
      <title>Morningstar: Stealth Growth Stock</title>
      <link>http://seekingalpha.com/article/46655-morningstar-stealth-growth-stock?source=feed</link>
      <guid isPermaLink="false">46655</guid>
      <content>
        <![CDATA[<p>

 
</p>
<p>I am initiating coverage of Morningstar, Inc. (MORN) with a buy rating and a price target of $72.00. <!--more-->Since going public in 2005, the company has put up double digit earnings and revenue growth, while doubling its assets under advisement from a year ago to nearly $81.5 billion. Favorable secular trends and a business model that achieves operating leverage will allow for further growth going forward. An economic moat is provided by the company's branding, unique content, and deep databases that are time consuming and difficult to replicate.
</p>]]>
      </content>
      <pubDate>Fri, 07 Sep 2007 05:03:53 -0400</pubDate>
      <author>Paul Simenauer</author>
      <description>
        <![CDATA[<strong><a href="http://stockslinger.blogspot.com/">Paul Simenauer</a> submits: </strong><p>

 
</p>
<p>I am initiating coverage of Morningstar, Inc. (MORN) with a buy rating and a price target of $72.00. <!--more-->Since going public in 2005, the company has put up double digit earnings and revenue growth, while doubling its assets under advisement from a year ago to nearly $81.5 billion. Favorable secular trends and a business model that achieves operating leverage will allow for further growth going forward. An economic moat is provided by the company's branding, unique content, and deep databases that are time consuming and difficult to replicate.
</p><br/><a href='http://seekingalpha.com/article/46655-morningstar-stealth-growth-stock?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/morn">MORN</category>
      <category type="author" link="http://seekingalpha.com/author/paul-simenauer">Paul Simenauer</category>
    </item>
    <item>
      <title>Where are the Markets Headed Next?</title>
      <link>http://seekingalpha.com/article/37089-where-are-the-markets-headed-next?source=feed</link>
      <guid isPermaLink="false">37089</guid>
      <content>
        <![CDATA[There seems to be confusion as to where equity markets are headed next. I could easily be wrong, but it seems that this bull market will continue carrying on. <!--more-->Private equity funds have been taking companies off the exchanges, creating an imbalance of supply and demand for stocks, while creating a reflexive relationship along with this imbalance: as companies are taken private, more and more market participants bid up potential buyout candidates in hopes that their stock receives a bad. Fueled by relatively low interest rates globally, the PE guys are acting rationally, not withstanding quick rate hikes by central banks in the near future. Valuations on a relative basis aren't obscene, yet, either, nor are relative valuations extremely cheap.
</p>
<p>Even though the US domestic economy looks like it is slowing down, many larger mega-cap companies can now be thought of as truly global organizations who happen to be head quartered in the United States, and fundamentals in global markets remain strong. At the same time, economists see the Federal Reserve lowering rates in the Fall to ease possible job market woes. An easing of US interest rates will only serve to support this bull market.
</p>]]>
      </content>
      <pubDate>Fri, 01 Jun 2007 04:56:36 -0400</pubDate>
      <author>Paul Simenauer</author>
      <description>
        <![CDATA[<strong><a href="http://stockslinger.blogspot.com/">Paul Simenauer</a> submits: </strong>There seems to be confusion as to where equity markets are headed next. I could easily be wrong, but it seems that this bull market will continue carrying on. <!--more-->Private equity funds have been taking companies off the exchanges, creating an imbalance of supply and demand for stocks, while creating a reflexive relationship along with this imbalance: as companies are taken private, more and more market participants bid up potential buyout candidates in hopes that their stock receives a bad. Fueled by relatively low interest rates globally, the PE guys are acting rationally, not withstanding quick rate hikes by central banks in the near future. Valuations on a relative basis aren't obscene, yet, either, nor are relative valuations extremely cheap.
</p>
<p>Even though the US domestic economy looks like it is slowing down, many larger mega-cap companies can now be thought of as truly global organizations who happen to be head quartered in the United States, and fundamentals in global markets remain strong. At the same time, economists see the Federal Reserve lowering rates in the Fall to ease possible job market woes. An easing of US interest rates will only serve to support this bull market.
</p><br/><a href='http://seekingalpha.com/article/37089-where-are-the-markets-headed-next?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/adre">ADRE</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ewz">EWZ</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/fxf">FXF</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/fxi">FXI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ifn">IFN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pbw">PBW</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pho">PHO</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/puw">PUW</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/vwo">VWO</category>
      <category type="author" link="http://seekingalpha.com/author/paul-simenauer">Paul Simenauer</category>
    </item>
    <item>
      <title>Get Sold: The Prescription for Unlocking Gateway's Value </title>
      <link>http://seekingalpha.com/article/32112-get-sold-the-prescription-for-unlocking-gateway-s-value?source=feed</link>
      <guid isPermaLink="false">32112</guid>
      <content>
        <![CDATA[It is my belief that Gateway Inc. (GTW) should be sold to a strategic acquirer as soon as possible as the company has failed to create value for shareholders, which is evidenced by the company’s depressed stock price. <!--more-->Gateway already got in touch with Goldman Sachs (GS) regarding an acquisition back on August 23rd, 2006 to be acquired by entrepreneur Lap Shun John Hui, but the deal has failed to materialize. Rumors also suggest that Taiwanese computer maker Acer may be interested, although Gateway had denied this link. 

<p>Gateway has significantly lagged the S&P 500 and the Dow Jones Computer Hardware Index, has had poor returns on assets and equity, has not realized any value creation through the acquisition of eMachines, and will struggle to compete against more heavily capitalized, efficient competitors. Gateway’s management does not look shareholder friendly, either. Nonetheless, Gateway has 3 key assets that should make it attractive to a strategic buyer if the company was sold.
</p>
<p><strong>Destruction of Value</strong>
</p>]]>
      </content>
      <pubDate>Thu, 12 Apr 2007 04:58:45 -0400</pubDate>
      <author>Paul Simenauer</author>
      <description>
        <![CDATA[<strong><a href="http://stockslinger.blogspot.com/">Paul Simenauer</a> submits: </strong>It is my belief that Gateway Inc. (GTW) should be sold to a strategic acquirer as soon as possible as the company has failed to create value for shareholders, which is evidenced by the company’s depressed stock price. <!--more-->Gateway already got in touch with Goldman Sachs (GS) regarding an acquisition back on August 23rd, 2006 to be acquired by entrepreneur Lap Shun John Hui, but the deal has failed to materialize. Rumors also suggest that Taiwanese computer maker Acer may be interested, although Gateway had denied this link. 

<p>Gateway has significantly lagged the S&P 500 and the Dow Jones Computer Hardware Index, has had poor returns on assets and equity, has not realized any value creation through the acquisition of eMachines, and will struggle to compete against more heavily capitalized, efficient competitors. Gateway’s management does not look shareholder friendly, either. Nonetheless, Gateway has 3 key assets that should make it attractive to a strategic buyer if the company was sold.
</p>
<p><strong>Destruction of Value</strong>
</p><br/><a href='http://seekingalpha.com/article/32112-get-sold-the-prescription-for-unlocking-gateway-s-value?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/gtw">GTW</category>
      <category type="author" link="http://seekingalpha.com/author/paul-simenauer">Paul Simenauer</category>
    </item>
    <item>
      <title>Why Heelys' Fifteen Minutes Are Up</title>
      <link>http://seekingalpha.com/article/30937-why-heelys-fifteen-minutes-are-up?source=feed</link>
      <guid isPermaLink="false">30937</guid>
      <content>
        <![CDATA[I believe that Heelys' (HLYS) business is unsustainable. I would recommend shorting their stock as Heelys shoes are a passing fad and the company is built around a single shoe product that is heavily reliant on the tastes of 6-10 year olds. <!--more-->

<p>As Heelys were a popular gift for children this holiday season, it's not too surprising to see the company post 4th quarter earnings that  beat Wall Street numbers handily. Net income for the fourth quarter of 2007 increased 700 percent to $11.5 million from $1.4 million the prior year, while earnings per share increased to 44 cents per share from 6 cents per share in the prior year period. The Street was looking for earnings of 28 cents per share. 
</p>
<p><strong>The Short Case: </strong>Analyst’s estimates of growth are overly optimistic. According to Capital IQ, growth for this year is forecasted at 20.7% for this year and 22.5% for the next 5 years. Heelys is expected to have earnings per share of $1.67, with around 83% of their earnings coming from 4th quarter holiday sales in 2007. This leaves little room for error, and it is questionable if Heelys was creating shareholder value to begin with. Cash flow from operations in 2006 was  -$2,180,000.00, and Free cash flow for 2006 was -$2,573,475.00.  
</p>]]>
      </content>
      <pubDate>Wed, 28 Mar 2007 14:10:13 -0400</pubDate>
      <author>Paul Simenauer</author>
      <description>
        <![CDATA[<strong><a href="http://stockslinger.blogspot.com/">Paul Simenauer</a> submits: </strong>I believe that Heelys' (HLYS) business is unsustainable. I would recommend shorting their stock as Heelys shoes are a passing fad and the company is built around a single shoe product that is heavily reliant on the tastes of 6-10 year olds. <!--more-->

<p>As Heelys were a popular gift for children this holiday season, it's not too surprising to see the company post 4th quarter earnings that  beat Wall Street numbers handily. Net income for the fourth quarter of 2007 increased 700 percent to $11.5 million from $1.4 million the prior year, while earnings per share increased to 44 cents per share from 6 cents per share in the prior year period. The Street was looking for earnings of 28 cents per share. 
</p>
<p><strong>The Short Case: </strong>Analyst’s estimates of growth are overly optimistic. According to Capital IQ, growth for this year is forecasted at 20.7% for this year and 22.5% for the next 5 years. Heelys is expected to have earnings per share of $1.67, with around 83% of their earnings coming from 4th quarter holiday sales in 2007. This leaves little room for error, and it is questionable if Heelys was creating shareholder value to begin with. Cash flow from operations in 2006 was  -$2,180,000.00, and Free cash flow for 2006 was -$2,573,475.00.  
</p><br/><a href='http://seekingalpha.com/article/30937-why-heelys-fifteen-minutes-are-up?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/hlys">HLYS</category>
      <category type="author" link="http://seekingalpha.com/author/paul-simenauer">Paul Simenauer</category>
    </item>
    <item>
      <title>What Does Third Point See in PDL Biopharma?</title>
      <link>http://seekingalpha.com/article/30497-what-does-third-point-see-in-pdl-biopharma?source=feed</link>
      <guid isPermaLink="false">30497</guid>
      <content>
        <![CDATA[PDL Biopharma, Inc. (PDLI) is a biotech company that has squandered cash on needless acqusitions and undisciplined R&D spending, depressing its stock price. <!--more-->On the upside, however, according to Third Point's <a href="http://biotech.seekingalpha.com/article/30413">filing</a>, the company gets hundreds of millions of dollars in royalties from Genentech's (DNA) Avastin and Herceptin. Specialty pharmaceutical revenues should approximate $200M in 2007 and the Company has other valuable assets: an exciting, albeit slowly-progressing, product pipeline; undisclosed royalties that extend beyond 2014; approximately $430M in net operating loss carry-forwards; real estate and other assets that can be monetized; and a valuable antibody technology platform that should continue to generate new compounds over time. 

<p>On March 5th, Third Point, LLC purchased 8.6 million shares in PDL Biopharma. The intent of this transaction is explained in Item 4 of the 13-D as follows:
</p>
<blockquote class="quote"><p>On March 5, 2007, the Management Company sent a letter to Mark McDade, Chief Executive Officer of the Company, and to the Board of Directors of the Company, expressing disappointment and concern over the Company's high rate of spending and, in the view of the Management Company, the Company's significant underperformance. In the letter, the Management Company urges that the Company cut costs and not pursue additional acquisitions. The Management Company communicated its belief that pipeline development and cash flow generation are not mutually exclusive and that, accordingly, the Company should reduce its spending to focus on essential product development and research. The Management Company has offered to work with management to streamline the Company's cost structure and asset base as soon as possible, in an effort to allow the cash generating ability and value of the Company to be developed and made apparent to shareholders. (Third Point LLC 13-D PDLI)<br />
</p></blockquote>]]>
      </content>
      <pubDate>Fri, 23 Mar 2007 06:00:32 -0400</pubDate>
      <author>Paul Simenauer</author>
      <description>
        <![CDATA[<strong><a href="http://stockslinger.blogspot.com/">Paul Simenauer</a> submits: </strong>PDL Biopharma, Inc. (PDLI) is a biotech company that has squandered cash on needless acqusitions and undisciplined R&D spending, depressing its stock price. <!--more-->On the upside, however, according to Third Point's <a href="http://biotech.seekingalpha.com/article/30413">filing</a>, the company gets hundreds of millions of dollars in royalties from Genentech's (DNA) Avastin and Herceptin. Specialty pharmaceutical revenues should approximate $200M in 2007 and the Company has other valuable assets: an exciting, albeit slowly-progressing, product pipeline; undisclosed royalties that extend beyond 2014; approximately $430M in net operating loss carry-forwards; real estate and other assets that can be monetized; and a valuable antibody technology platform that should continue to generate new compounds over time. 

<p>On March 5th, Third Point, LLC purchased 8.6 million shares in PDL Biopharma. The intent of this transaction is explained in Item 4 of the 13-D as follows:
</p>
<blockquote class="quote"><p>On March 5, 2007, the Management Company sent a letter to Mark McDade, Chief Executive Officer of the Company, and to the Board of Directors of the Company, expressing disappointment and concern over the Company's high rate of spending and, in the view of the Management Company, the Company's significant underperformance. In the letter, the Management Company urges that the Company cut costs and not pursue additional acquisitions. The Management Company communicated its belief that pipeline development and cash flow generation are not mutually exclusive and that, accordingly, the Company should reduce its spending to focus on essential product development and research. The Management Company has offered to work with management to streamline the Company's cost structure and asset base as soon as possible, in an effort to allow the cash generating ability and value of the Company to be developed and made apparent to shareholders. (Third Point LLC 13-D PDLI)<br />
</p></blockquote><br/><a href='http://seekingalpha.com/article/30497-what-does-third-point-see-in-pdl-biopharma?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/pdli">PDLI</category>
      <category type="author" link="http://seekingalpha.com/author/paul-simenauer">Paul Simenauer</category>
    </item>
    <item>
      <title>Syneron: Well-Equipped for Success </title>
      <link>http://seekingalpha.com/article/29660-syneron-well-equipped-for-success?source=feed</link>
      <guid isPermaLink="false">29660</guid>
      <content>
        <![CDATA[Syneron (ELOS) sells medical products, which make use of their proprietary ELOS technology, to the cosmetic surgery industry.<!--more--> Demographics for this industry are favorable, allowing for strong potential growth opportunities. As the baby boomer generation ages, demand for Syneron’s products will likely increase as boomers seek to look younger. 

<p>Moreover, Syneron is a highly profitable business that generates strong free cash flow. In fiscal 2005, the company generated nearly $30 million in owner’s earnings and had net margins of 27%. The main value driver behind Syneron is their low cost structure and extremely low tax rate on operating income of 2%, compared to the corporate tax rates of competitors of approximately 35%. I calculated a $42 stock price from my DCF model, and gave myself a 20% margin of safety to arrive at a conservative estimate of value at $34.00 per share, using a discount rate of 17%. If you would like to see my DCF model, it is available upon request via e-mail.       
</p>
<p><strong>
<br />
Background</strong>
</p>]]>
      </content>
      <pubDate>Thu, 15 Mar 2007 07:17:39 -0400</pubDate>
      <author>Paul Simenauer</author>
      <description>
        <![CDATA[<strong><a href="http://stockslinger.blogspot.com/">Paul Simenauer</a> submits: </strong>Syneron (ELOS) sells medical products, which make use of their proprietary ELOS technology, to the cosmetic surgery industry.<!--more--> Demographics for this industry are favorable, allowing for strong potential growth opportunities. As the baby boomer generation ages, demand for Syneron’s products will likely increase as boomers seek to look younger. 

<p>Moreover, Syneron is a highly profitable business that generates strong free cash flow. In fiscal 2005, the company generated nearly $30 million in owner’s earnings and had net margins of 27%. The main value driver behind Syneron is their low cost structure and extremely low tax rate on operating income of 2%, compared to the corporate tax rates of competitors of approximately 35%. I calculated a $42 stock price from my DCF model, and gave myself a 20% margin of safety to arrive at a conservative estimate of value at $34.00 per share, using a discount rate of 17%. If you would like to see my DCF model, it is available upon request via e-mail.       
</p>
<p><strong>
<br />
Background</strong>
</p><br/><a href='http://seekingalpha.com/article/29660-syneron-well-equipped-for-success?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/elos">ELOS</category>
      <category type="author" link="http://seekingalpha.com/author/paul-simenauer">Paul Simenauer</category>
    </item>
    <item>
      <title>Reverse Mergers: The APO (Alternative Public Offerings) Part I</title>
      <link>http://seekingalpha.com/article/28881-reverse-mergers-the-apo-alternative-public-offerings-part-i?source=feed</link>
      <guid isPermaLink="false">28881</guid>
      <content>
        <![CDATA[While the traditional IPO has been the normal way for a company to go public, it is questionable whether this practice is the best method for all companies to go public, and if more innovative ways of going public may be a better way to go. <!--more-->The three main vehicles for doing an alternative public offering include the following:
</p>
<blockquote><p>1. <a href="http://www.reversemerger.com">Reverse Mergers</a>
<br />
2. Specialty Acquisition Corporations
<br />
3. Dutch auctions
</p></blockquote>]]>
      </content>
      <pubDate>Wed, 07 Mar 2007 05:43:47 -0500</pubDate>
      <author>Paul Simenauer</author>
      <description>
        <![CDATA[<strong><a href="http://stockslinger.blogspot.com/">Paul Simenauer</a> submits: </strong>While the traditional IPO has been the normal way for a company to go public, it is questionable whether this practice is the best method for all companies to go public, and if more innovative ways of going public may be a better way to go. <!--more-->The three main vehicles for doing an alternative public offering include the following:
</p>
<blockquote><p>1. <a href="http://www.reversemerger.com">Reverse Mergers</a>
<br />
2. Specialty Acquisition Corporations
<br />
3. Dutch auctions
</p></blockquote><br/><a href='http://seekingalpha.com/article/28881-reverse-mergers-the-apo-alternative-public-offerings-part-i?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="author" link="http://seekingalpha.com/author/paul-simenauer">Paul Simenauer</category>
    </item>
    <item>
      <title>Bullish On The Yen Following The Selloff</title>
      <link>http://seekingalpha.com/article/28305-bullish-on-the-yen-following-the-selloff?source=feed</link>
      <guid isPermaLink="false">28305</guid>
      <content>
        <![CDATA[After the sharp global sell off in stocks that occured on February 27th, it has become apparent to me that the low volatility seen in the markets will not last. This poses a serious threat to anyone who has a position in the Yen carry trade, which can be seen in the Yen's appreciation during Tuesday's sell off in the equities markets. In many ways, the carry trade is a classic case of reflexivity, where one's actions influence valuation and events that do not reflect reality. <!--more-->
</p>
<p><strong>Summary:</strong> The Yen is currently undervalued, and should appreciate relative to other currencies. Nevertheless, speculators continue to implement a Yen carry trade, artificially pushing down the value of the Yen in the near term, and earning a profit on the spread between Japanese interest rates which are at .5%, and interest rates in other markets such as the United States, which are currently at 5.25%. This is a distortion of fundamental reality, and eventually markets will reflect the true value of the Yen sooner or later.
<br />
<strong>
<br />
Background: </strong>Japan experienced strong deflationary pressures following the collapse of its asset market bubble that lasted from 1986-1990. During this period, the land around the palace in Tokyo was worth more than all the real estate in California at the time. Japan’s economy recovered during the 1990’s, and saw a growth of +50% in the Nikkei in 2006.
</p>]]>
      </content>
      <pubDate>Wed, 28 Feb 2007 10:11:20 -0500</pubDate>
      <author>Paul Simenauer</author>
      <description>
        <![CDATA[<strong><a href="http://stockslinger.blogspot.com/">Paul Simenauer</a> submits: </strong>After the sharp global sell off in stocks that occured on February 27th, it has become apparent to me that the low volatility seen in the markets will not last. This poses a serious threat to anyone who has a position in the Yen carry trade, which can be seen in the Yen's appreciation during Tuesday's sell off in the equities markets. In many ways, the carry trade is a classic case of reflexivity, where one's actions influence valuation and events that do not reflect reality. <!--more-->
</p>
<p><strong>Summary:</strong> The Yen is currently undervalued, and should appreciate relative to other currencies. Nevertheless, speculators continue to implement a Yen carry trade, artificially pushing down the value of the Yen in the near term, and earning a profit on the spread between Japanese interest rates which are at .5%, and interest rates in other markets such as the United States, which are currently at 5.25%. This is a distortion of fundamental reality, and eventually markets will reflect the true value of the Yen sooner or later.
<br />
<strong>
<br />
Background: </strong>Japan experienced strong deflationary pressures following the collapse of its asset market bubble that lasted from 1986-1990. During this period, the land around the palace in Tokyo was worth more than all the real estate in California at the time. Japan’s economy recovered during the 1990’s, and saw a growth of +50% in the Nikkei in 2006.
</p><br/><a href='http://seekingalpha.com/article/28305-bullish-on-the-yen-following-the-selloff?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/fxy">FXY</category>
      <category type="author" link="http://seekingalpha.com/author/paul-simenauer">Paul Simenauer</category>
    </item>
    <item>
      <title>The Long Case For Idearc</title>
      <link>http://seekingalpha.com/article/24140-the-long-case-for-idearc?source=feed</link>
      <guid isPermaLink="false">24140</guid>
      <content>
        <![CDATA[In November 2006, Verizon (VZ) <a href="http://telecom.seekingalpha.com/article/20863">spunoff</a> its directories business into a new entity called Idearc (IAR). I see a lot of upside potential in IAR and believe it offers a nice risk-reward scenario. <!--more-->

<p>Spinoffs have historically outpeformed the market for a variety of reasons. This often occurs because the stock is not widely followed after heavy institutional selling is not based on the stock's investment merits, thus creating a pocket of market inefficiency for us to exploit. Additionally, management in many cases is given strong incentive to perform with a large portion of the newly created entity's stock allocated to management. Often times in spinoffs the new company has debt from its parent layered on its capital structure, which creates a leveraged finance type opportunity. By buying at a margin of safety, we can create an asymmetrical risk reward scenario.
</p>
<p>In fact, Idearc shares several of these characteristics common in spinoffs. Its market capitalization is only a billion dollars, which makes it far smaller than Verizon, and has forced large institutions, regulated by investment charters that say they can only invest in large capitalization stocks, to sell. A large portion of Idearc's shares, approximately 40% of the float, have been allocated to management tying their compensation to their performance, and giving them strong incentive to do a decent job for shareholders. It also has been given a large amount of Verizon's debt, which has created the leveraged finance type play I mentioned above, and will enforce managerial discipline.
</p>]]>
      </content>
      <pubDate>Tue, 16 Jan 2007 03:00:34 -0500</pubDate>
      <author>Paul Simenauer</author>
      <description>
        <![CDATA[<strong><a href="http://stockslinger.blogspot.com/">Paul Simenauer</a> submits: </strong>In November 2006, Verizon (VZ) <a href="http://telecom.seekingalpha.com/article/20863">spunoff</a> its directories business into a new entity called Idearc (IAR). I see a lot of upside potential in IAR and believe it offers a nice risk-reward scenario. <!--more-->

<p>Spinoffs have historically outpeformed the market for a variety of reasons. This often occurs because the stock is not widely followed after heavy institutional selling is not based on the stock's investment merits, thus creating a pocket of market inefficiency for us to exploit. Additionally, management in many cases is given strong incentive to perform with a large portion of the newly created entity's stock allocated to management. Often times in spinoffs the new company has debt from its parent layered on its capital structure, which creates a leveraged finance type opportunity. By buying at a margin of safety, we can create an asymmetrical risk reward scenario.
</p>
<p>In fact, Idearc shares several of these characteristics common in spinoffs. Its market capitalization is only a billion dollars, which makes it far smaller than Verizon, and has forced large institutions, regulated by investment charters that say they can only invest in large capitalization stocks, to sell. A large portion of Idearc's shares, approximately 40% of the float, have been allocated to management tying their compensation to their performance, and giving them strong incentive to do a decent job for shareholders. It also has been given a large amount of Verizon's debt, which has created the leveraged finance type play I mentioned above, and will enforce managerial discipline.
</p><br/><a href='http://seekingalpha.com/article/24140-the-long-case-for-idearc?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/idarq.pk">IDARQ.PK</category>
      <category type="author" link="http://seekingalpha.com/author/paul-simenauer">Paul Simenauer</category>
    </item>
  </channel>
</rss>
